Detalles de la búsqueda
1.
Underweight status at diagnosis is associated with poorer outcomes in adult patients with acute myeloid leukemia: a retrospective study of JALSG AML 201.
Ann Hematol
; 97(1): 73-81, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29196987
2.
The demarcation between younger and older acute myeloid leukemia patients: a pooled analysis of 3 prospective studies.
Cancer
; 119(18): 3326-33, 2013 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23798329
3.
Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study.
Blood
; 117(8): 2358-65, 2011 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-20693429
4.
A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study.
Blood
; 117(8): 2366-72, 2011 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-21190996
5.
[Anti-smoking education for tobacco-free society].
Nihon Rinsho
; 71(3): 527-32, 2013 Mar.
Artículo
en Japonés
| MEDLINE | ID: mdl-23631248
6.
Effect of landscape design on depth perception in classical Chinese gardens: A quantitative analysis using virtual reality simulation.
Front Psychol
; 13: 963600, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36405211
7.
A phase II randomized study evaluating azacitidine versus conventional care regimens in newly diagnosed elderly Japanese patients with unfavorable acute myeloid leukemia.
Int J Hematol
; 115(5): 694-703, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35211840
8.
[Phase I study of nelarabine in patients with relapsed or refractory T-ALL/T-LBL].
Rinsho Ketsueki
; 52(6): 406-15, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21737993
9.
Effect of Wall Texture on Perceptual Spaciousness of Indoor Space.
Int J Environ Res Public Health
; 17(11)2020 06 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32545379
10.
CMC-544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells: analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukaemia and lymphoma.
Br J Haematol
; 146(1): 34-43, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19388933
11.
Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapy.
Br J Haematol
; 143(4): 503-10, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18986386
12.
Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy.
Haematologica
; 93(2): 287-90, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18223280
13.
Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol.
Int J Hematol
; 87(2): 144-151, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18256787
14.
Treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Curr Oncol Rep
; 10(5): 379-87, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18706265
15.
Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival rates.
Leuk Res
; 31(7): 907-14, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17005250
16.
Prediction of risk of disease recurrence by genome-wide cDNA microarray analysis in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy.
Int J Oncol
; 31(2): 313-22, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17611687
17.
Phase I trial of FLAGM with high doses of cytosine arabinoside for relapsed, refractory acute myeloid leukemia: study of the Japan Adult Leukemia Study Group (JALSG).
Int J Hematol
; 86(4): 343-7, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18055342
18.
Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide.
Cancer Chemother Pharmacol
; 59(4): 485-93, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16937107
19.
Molecular target-based treatment of human cancer: summary of the 10th international conference on differentiation therapy.
Cancer Res
; 65(4): 1117-23, 2005 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15734991
20.
Impact of additional chromosomal abnormalities in patients with acute promyelocytic leukemia: 10-year results of the Japan Adult Leukemia Study Group APL97 study.
Haematologica
; 96(1): 174-6, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20884714